Epidemiology of pseudomonas aeruginosa in the intensive care unit

Infectious Diseases in Critical Care

Volumn , Issue , 2007, Pages 218-225

  Wunderink, R G ^a   Mendoza, D L ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Capio Hospital Sur   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 48049100485     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-34406-3_20     Document Type: Chapter

References (97)

1. Hoiby N (1974) Pseudomonas aeruginosa infection in cystic fibrosis. Relationship betweenmucoid strains of Pseudomonas aeruginosa and the humoral immune response. Acta Pathol Microbiol Scand [B] Microbiol Immunol 82(4):551-558
2. Morrison AJ Jr, Wenzel RP (1984) Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 6 (Suppl 3): S627-642
3. Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29(Suppl A):19-24
4. Richards MJ, Edwards JR, Culver DH, et al. (1999) Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27(5):887-892
5. Spencer RC (1996) Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis 15(4):281-285
6. Gales AC, Jones RN, Turnidge J, et al. (2001) Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32 (Suppl 2): S146-155
7. Cross AS (1985) Evolving epidemiology of Pseudomonas aeruginosa infections. Eur J Clin Microbiol 4(2):156-159
8. Glupczynski Y, Delmee M, Goossens H, et al. (2001) Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units (ICU) in Belgian hospitals between 1996 and 1999. Acta Clin Belg 56(5):297-306
9. Fridkin SK, Gaynes RP (1999) Antimicrobial resistance in intensive care units. Clin Chest Med 20(2):303-316, viii
10. Trouillet JL, Chastre J, Vuagnat A, et al. (1998) Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157(2):531-539
11. Trouillet JL, Vuagnat A, Combes A, et al. (2002) Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillinsusceptible organisms. Clin Infect Dis 34(8):1047-1054
12. Vincent JL (2000) Microbial resistance: lessons from the EPIC study. European Prevalence of Infection. Intensive Care Med 26 (Suppl 1): S3-8
13. Vincent JL, Bihari DJ, Suter PM, et al. (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274(8):639-644
14. Fagon JY, Chastre J, Vuagnat A, et al. (1996) Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 275(11):866-869
15. Kominos SD, Copeland CE, Grosiak B, et al. (1972) Introduction of Pseudomonas aeruginosa into a hospital via vegetables. Appl Microbiol 24(4):567-570
16. Shooter RA, Cooke EM, Faiers MC, et al. (1971) Isolation of Escherichia coli, Pseudomonas aeruginosa, and Klebsiella from food in hospitals, canteens, and schools. Lancet 2(7721):390-392
17. Bertrand X, Thouverez M, Talon D, et al. (2001) Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med 27(8):1263-1268
18. Blanc DS, Petignat C, Janin B, et al. (1998) Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. Clin Microbiol Infect 4(5):242-247
19. Struelens MJ, Rost F, Deplano A, et al. (1993) Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am J Med 95(5):489-498
20. Trautmann M, Michalsky T, Wiedeck H, et al. (2001) Tap water colonization with Pseudomonas aeruginosa in a surgical intensive care unit (ICU) and relation to Pseudomonas infections of ICU patients. Infect Control Hosp Epidemiol 22(1):49-52
21. Blanc DS, Nahimana I, Petignat C, et al. (2004) Faucets as a reservoir of endemic Pseudomonas aeruginosa colonization/infections in intensive care units. Intensive Care Med 30(10):1964-1968
22. Foca M, Jacob K, Whittier S, et al. (2000) Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med 343(10):695-700
23. McNeil SA, Nordstrom-Lerner L, Malani PN, et al. (2001) Outbreak of sternal surgical site infections due to Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis. Clin Infect Dis 33(3):317-323
24. Moolenaar RL, Crutcher JM, San Joaquin VH, et al. (2000) A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol 21(2):80-85
25. Wenzel RP (1994) Healthcare workers and the incidence of nosocomial infection: can treatment of one influence the other?-a brief review. J Chemother 6(Suppl 4):33-37
26. Widmer AF, Wenzel RP, Trilla A, et al. (1993) Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care worker. Clin Infect Dis 16(3):372-376
27. Pollack M, Pier GB, Prescott RK (1984) Immunization with Pseudomonas aeruginosa high-molecular-weight polysaccharides prevents death from Pseudomonas burn infections in mice. Infect Immun 43(2):759-760
28. Lowbury EJ, Thom BT, Lilly HA, et al. (1970) Sources of infection with Pseudomonas aeruginosa in patients with tracheostomy. J Med Microbiol 3(1):39-56
29. Woods DE, Schaffer MS, Rabin HR, et al. (1986) Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol 24(2):260-264
30. Grundmann H, Schneider C, Hartung D, et al. (1995) Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. J Clin Microbiol 33(3):528-534
31. Thuong M, Arvaniti K, Ruimy R, et al. (2003) Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. J Hosp Infect 53(4):274-282
32. Speijer H, Savelkoul PH, Bonten MJ, et al. (1999) Application of different genotypingmethods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 37(11):3654-3661
33. Tyler KD, Wang G, Tyler SD, et al. (1997) Factors affecting reliability and reproducibility of amplification-based DNA fingerprinting of representative bacterial pathogens. J Clin Microbiol 35(2):339-346
34. Tenover FC, Arbeit RD, Goering RV, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33(9):2233-2239
35. Bergmans DC, Bonten MJ, van Tiel FH, et al. (1998) Crosscolonisation with Pseudomonas aeruginosa of patients in an intensive care unit. Thorax 53(12):1053-1058
36. Berthelot P, Grattard F, Mahul P, et al. (2001) Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med 27(3):503-512
37. Bonten MJ, Bergmans DC, Speijer H, et al. (1999) Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control. Am J Respir Crit Care Med 160(4):1212-1219
38. Richards MJ, Edwards JR, Culver DH, et al. (2000) Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21(8):510-515
39. Panceri ML, Vegni FE, Goglio A, et al (2004) Aetiology and prognosis of bacteraemia in Italy. Epidemiol Infect 132(4):647-654
40. Wisplinghoff H, Bischoff T, Tallent SM, et al. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3):309-317
41. Osmon S, Ward S, Fraser VJ, et al. (2004) Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 125(2):607-616
42. Pawar M, Mehta Y, Khurana P, et al. (2003) Ventilator-associated pneumonia: Incidence, risk factors, outcome, and microbiology. J Cardiothorac Vasc Anesth 17(1):22-28
43. Talon D, Mulin B, Rouget C, et al. (1998) Risks and routes for ventilator-associated pneumonia with Pseudomonas aeruginosa. Am J Respir Crit Care Med 157:978-984
44. Baddour LM, Hicks DV, Tayidi MM, et al. (1995) Risk factor assessment for the acquisition of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa in a communitybased hospital. Microb Drug Resist 1(3):219-222
45. Carmeli Y, Troillet N, Eliopoulos GM, et al. (1999) Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 43(6):1379-1382
46. Talon D, Capellier G, Boillot A, et al (1995) Use of pulsedfield gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit. Intensive Care Med 21(12):996-1002
47. Bert F, Maubec E, Bruneau B, et al. (1998) Multi-resistant Pseudomonas aeruginosa outbreak associated with contaminated tap water in a neurosurgery intensive care unit. J Hosp Infect 39(1):53-62
48. Cobben NA, Drent M, Jonkers M, et al. (1996) Outbreak of severe Pseudomonas aeruginosa respiratory infections due to contaminated nebulizers. J Hosp Infect 33(1):63-70
49. Rutala WA, Weber DJ (1997) Water as a reservoir of nosocomial pathogens. Infect Control Hosp Epidemiol 18(9):609-616
50. Gruner E, Kropec A, Huebner J, et al. (1993) Ribotyping of Pseudomonas aeruginosa strains isolated fromsurgical intensive care patients. J Infect Dis 167(5):1216-1220
51. Kropec A, Huebner J, Riffel M, et al. (1993) Exogenous or endogenous reservoirs of nosocomial Pseudomonas aeruginosa and Staphylococcus aureus infections in a surgical intensive care unit. Intensive Care Med 19(3):161-165
52. Rello J, Jubert P, Valles J, et al. (1996) Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 23(5):973-978
53. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001(August 2001). Am J Infect Control 29 (6):404-421
54. Richards MJ, Edwards JR, Culver DH, et al. (1999) Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 103(4):39
55. Blanc DS, Parret T, Janin B, et al. (1997) Nosocomial infections and pseudoinfections from contaminated bronchoscopes: two-year follow up using molecular markers. Infect Control Hosp Epidemiol 18(2):134-136
56. Doring G, Horz M, Ortelt J, et al. (1993) Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit. Epidemiol Infect 110(3):427-436
57. Kollef MH (1999) The prevention of ventilator-associated pneumonia. N Engl J Med 340(8):627-634
58. Richard P, Le Floch R, Chamoux C, et al. (1994) Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence ofmultiply resistant strains. J Infect Dis 170(2):377-383
59. Tredget EE, Shankowsky HA, Joffe AM, et al. (1992) Epidemiology of infections with Pseudomonas aeruginosa in burn patients: the role of hydrotherapy. Clin Infect Dis 15(6):941-949
60. Pellegrino FL, Teixeira LM, Carvalho MD Mda G, et al. (2002) Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J Clin Microbiol 40(7):2420-2424
61. Girlich D, Poirel L, Leelaporn A, et al (2001) Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol 39(1):175-182
62. Hocquet D, Bertrand X, Kholer T, et al. (2003) Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob Agents Chemother 47(6):1887-1894
63. Poirel L, Menuteau O, Agoli N, et al. (2003) Outbreak of extendedspectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 41(8):3542-3547
64. Poirel L, Naas T, Nicolas D, et al. (2000) Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44(4):891-897
65. Poirel L, Weldhagen GF, Naas T, et al. (2001) GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother 45(9):2598-2603
66. Poole K (2004) Efflux-mediated multiresistance in Gramnegative bacteria. Clin Microbiol Infect 10(1):12-26
67. Harris AD, Smith D, Johnson JA, et al. (2002) Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 34(3):340-345
68. Carmeli Y, Troillet N, Karchmer AW, et al. (1999) Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 159(10):1127-1132
69. Dever LA, Dermody TS (1991) Mechanisms of bacterial resistance to antibiotics. Arch Intern Med 151(5):886-895
70. Livermore DM (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34(5):634-640
71. Boles BR, Thoendel M, Singh PK (2004) Self-generated diversity produces "insurance effects" in biofilm communities. Proc Natl Acad Sci USA 101(47):16630-16635
72. Schulert GS, Feltman H, Rabin SD, et al. (2003) Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained frompatients with hospitalacquired pneumonia. J Infect Dis 188(11):1695-1706
73. Hauser AR, Cobb E, Bodi M, et al. (2002) Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 30(3):521-528
74. Saiman L, Ishimoto K, Lory S, et al. (1990) The effect of piliation and exoproduct expression on the adherence of Pseudomonas aeruginosa to respiratory epithelial monolayers. J Infect Dis 161(3):541-548
75. Woods DE, Straus DC, Johanson WG Jr, et al. (1981) Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest 68(6):1435-1440
76. Cosson P, Zulianello L, Join-Lambert O, et al. (2002) Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J Bacteriol 184(11):3027-3033
77. Pukatzki S, Kessin RH, Mekalanos JJ (2002) The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc Natl Acad Sci USA 99(5):3159-3164
78. Fenner L, Richet H, Raoult D, et al. (2006) Are clinical isolates of Pseudomonas aeruginosa more virulent than hospital environmental isolates in amebal co-culture test?. Crit Care Med 34(3):823-828
79. Bodey GP, Jadeja L, Elting, L (1985) Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 145(9):1621-1629
80. Siegman-Igra Y, Ravona R, Primerman H, et al. (1998) Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis 2(4):211-215
81. Rello J, Rue M, Jubert P, et al. (1997) Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 25(11):1862-1867
82. Rello J, Ausina V, Ricart M, et al. (1994) Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 20(3):193-198
83. Itokazu GS, Quinn JP, Bell-Dixon C, et al. (1996) Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis 23(4):779-784
84. Troillet N, Samore MH, Carmeli Y (1997) Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 25(5):1094-1098
85. Brun-Buisson C, Sollet JP, Schweich H, et al. (1998) Treatment of ventilator-associated pneumonia with piperacillintazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group. Clin Infect Dis 26(2):346-354
86. Fink MP, Snydman DR, Niederman MS, et al. (1994) Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother 38(3):547-557
87. Luyt CE, Guerin V, Combes A, et al. (2005) Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 171(1):48-53
88. Ibrahim EH, Ward S, Sherman G, et al. (2001) Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 29(6):1109-1115
89. Jackson BR, Thomas A, Caroll KC, et al. (2005) Use of strain typing data to estimate bacterial transmission rates in healthcare settings. Infect Control Hosp Epidemiol 26(7):638-645
90. Nagata T, Mukae H, Kadota J, et al. (2004) Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. Antimicrob Agents Chemother 48(6):2251-2259
91. Imamura Y, Yanagihara K, Mizuta Y, et al. (2004) Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-oxododecanoyl) homoserine lactone in NCI-H292 cells. Antimicrob Agents Chemother 48(9):3457-3461
92. Pittet D, Hugonnet S, Harbarth S, et al (2000) Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 356(9238):1307-1312
93. Schoenen D, Stoeck B, Hienzsch S, et al (1986) Decontamination of drinking water taps colonized with Pseudomonas aeruginosa. Zentralbl BakteriolMikrobiolHyg[B] 182(5-6):551-557
94. Trautmann M, Royer H, Helm E, et al. (2004) Pseudomonas aeruginosa: new insights into transmission pathways between hospital water and patients. Filtration 1(Suppl 1):63-70
95. Rello J, Ausina V, Ricart M, et al. (1993) Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 104(4):1230-1235
96. Vollaard EJ, Clasener HA (1994) Colonization resistance. Antimicrob Agents Chemother 38(3):409-414
97. Crawford J, Ozer H, Stoller R, et al. (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325(3):164-170